Anti-IL-6 antibody (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-IL-6 antibody (investigational), covering 2023-08-09 to 2023-08-09. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition [Phase 2]